Search clinical trials for: Sofosbuvir-Velpatasvir Drug Combination

Total 4884 results

National Nutrition and Food Technology Institute

Not yet recruiting

Grape Juice and Dermatitis in Breast Cancer

Breast Cancer
Clinical Nutrition Research Center, Illinois Institute...
USDA Beltsville Human Nutrition Research Center

Active, not recruiting

Berries, Inflammation, and Gut Microbiome

Healthy | Overweight or Obesity

United States
University of Kansas Medical Center
Penumbra Inc.

Completed

Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT (INDIGO)

Acute Deep Vein Thrombosis

United States
Pfizer

Completed

To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.

Rheumatoid Arthritis

United States
Seoul National University Bundang Hospital

Completed

Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study

Gastric Cancer

Korea, Republic of
Biosearch S.A.
Clínica Dr. Miguel Quesada

Completed

Effect of the Consumption of a Combination of Plant Extracts (BSL_EP026) on Serum Uric Acid.

Hyperuricemia

Spain
Sanjay Gandhi Postgraduate Institute of Medical...

Completed

Entecavir for Decompensated HBV Cirrhosis

Liver Cirrhosis | Hepatitis B

India
West Virginia University

Terminated

Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis (PIPE-CF)

Cystic Fibrosis

United States
Chinese PLA General Hospital

Unknown

Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation

Neutropenia | Hematopoietic Stem Cell Transplantation

China
London School of Hygiene and Tropical Medicine

Completed

Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in Mali (NECTAR4)

Malaria,Falciparum

Mali
Roswell Park Cancer Institute
National Comprehensive Cancer Network

Recruiting

Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8

United States
Daewoong Pharmaceutical Co. LTD.

Unknown

Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

Hypertension, Dyslipidemia

Korea, Republic of
AstraZeneca

Completed

AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics (TRUST)

SARS-CoV-2

United States, Belgium, United Kingdom, Brazil, Germany
AstraZeneca
University of Pittsburgh

Completed

eVusheld Assessment reaL wORld Effectiveness at UPMC (VALOR-C19 UPMC)

SARS-CoV-2, COVID-19

United States
Peking University Cancer Hospital & Institute

Enrolling by invitation

A Phase Ⅱ Trial of Neoadjuvant Toripalimab Plus Platinum-doublet Chemotherapy in Locally Advanced NSCLC.

Locally Advanced NSCLC

China
AbbVie

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection (Quartz II/III)

Chronic Hepatitis C Virus Infection
Peking Union Medical College Hospital

Unknown

Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE

Atherosclerosis

China
Centers for Disease Control and Prevention
Columbia University; United States Agency for International Development (USAID) and other collaborators

Completed

Ethiopia Antimalarial in Vivo Efficacy Study 2012

Plasmodium Vivax Infection

Ethiopia
New York State Psychiatric Institute

Completed

Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse (PAIN)

Opioid Dependence

United States
AstraZeneca

Not yet recruiting

eVusheld Assessment reaL wORld Effectiveness in DoD Health System (VALOR DoD)

COVID-19; SARS-CoV-2; 2019 Novel Coronavirus Disease
AstraZeneca

Completed

An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan (Evusheld DBR)

COVID-19

Japan
AstraZeneca
Clalit Health Services

Completed

eVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health Services (VALOR C19 IL)

COVID-19 | SARS-CoV-2

Israel
National Taiwan University Hospital
Merck Sharp & Dohme LLC

Completed

EBR/GZR for HCV-1b Patients Receiving Hemodialysis

Hepatitis C

Taiwan
Peking University Cancer Hospital & Institute

Unknown

Nab-PCE vs PC for MM After Failure of Anti-PD-1

Advanced Melanoma

China
Michael Savona
Incyte Corporation; Astex Pharmaceuticals, Inc.; Theradex

Recruiting

Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO) (ABNL-MARRO)

MDS/MPN

United States
Padagis LLC

Completed

Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris

Acne

United States
Heidelberg University
Ludwig-Maximilians - University of Munich; Jimma University

Withdrawn

Methylene Blue Against Vivax Malaria in Ethiopia (BlueAL)

Vivax Malaria
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy Volunteers

Healthy

Belgium
Gilead Sciences

Completed

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

Chronic Hepatitis C Infection

New Zealand
Novo Nordisk A/S

Completed

A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South Korea

Diabetes Mellitus, Type 2

Korea, Republic of
Menzies School of Health Research
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh

Malaria
Fundació Institut de Recerca de l'Hospital de la...

Recruiting

DBT Skills Expanded With Contextual Intervention for Long Lasting Symptoms in Borderline Personality Disorder (DBT+Context)

Borderline Personality Disorders | BPD

Spain
Zhongda Hospital

Recruiting

Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Ankara Etlik City Hospital

Completed

The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy

Bladder Cancer | Bladder Cancer Stage I | Bladder Cancer Stage II

Turkey
Zai Lab (Shanghai) Co., Ltd.

Terminated

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Advanced Hepatocellular Carcinoma (HCC)

China
NYU Langone Health
Eli Lilly and Company; The Cleveland Clinic; Centocor, Inc.

Completed

Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI

Myocardial Infarction

United States
Peking University First Hospital

Not yet recruiting

Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients

Type 2 Diabetes
Regor Pharmaceuticals Inc.

Recruiting

First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

Breast Cancer

United States
Miquel Pujol
Institut d'Investigació Biomèdica de Bellvitge; Instituto de Salud Carlos III

Terminated

Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With MSSA Bacteremia (SAFO)

Methicillin Susceptible Staphylococcus Aureus Septicemia

Spain
NewChapter, Inc.
Procter and Gamble

Completed

Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes

Prediabetes

United States
Vertex Pharmaceuticals Incorporated

Completed

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor

Cystic Fibrosis

United States, United Kingdom, Germany, Spain, Switzerland, Canada, Netherlands, Italy, Ireland, Sweden, France, Denmark
Cancer Research UK
Royal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of Birmingham

Recruiting

DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol (DETERMINE)

Solid Tumor | Haematological Malignancy

United Kingdom
Sunnybrook Health Sciences Centre
AstraZeneca

Withdrawn

Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL (PACE-CLL)

COVID-19 | Chronic Lymphocytic Leukemia

Canada
King's College Hospital NHS Trust
Merck Sharp & Dohme LLC; Hepatitis C Trust

Terminated

ATTIC - Access To Treat in the Community (ATTIC)

Hepatitis C, Chronic

United Kingdom
Albert Schweitzer Hospital
Medical University of Vienna

Completed

Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria (REPLAMO)

Malaria

Gabon
Institut de Recherche pour le Developpement
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand

HIV Infections

Thailand
Humanity and Health Research Centre
Beijing 302 Hospital

Completed

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients

Chronic Hepatitis C Infection

China
Sir Run Run Shaw Hospital
Hangzhou Neoantigen Therapeutics Co., Ltd.

Recruiting

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms

Digestive System Neoplasms

China
DSM Nutritional Products, Inc.
SynteractHCR

Completed

Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants

Healthy Infants

Spain
Catharina Ziekenhuis Eindhoven

Recruiting

Induction Chemotherapy for Locally Recurrent Rectal Cancer (PelvEx II)

Recurrent Rectal Cancer

Netherlands, Sweden, Belgium, Norway, Portugal

Search clinical trials for: Sofosbuvir-Velpatasvir Drug Combination

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations